Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,205.00
+41.80 (1.93%)
Apr 13, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 618.89 billion as of April 13, 2026. Its market cap has increased by 47.52% in one year.
Market Cap
618.89B
Enterprise Value
604.23B
Revenue
165.10B
Ranking
n/a
PE Ratio
58.11
Stock Price
2,205.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 618.89B, an increase of 53,749.55%. That is a compound annual growth rate of 28.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 610.46B | 6.29% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.62T |
| Cipla | 993.17B |
| Zydus Lifesciences | 921.11B |
| Mankind Pharma | 858.27B |
| Aurobindo Pharma | 783.73B |
| Alkem Laboratories | 650.43B |
| Laurus Labs | 592.95B |
| Ipca Laboratories | 369.44B |